BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
273 results:

  • 1. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
    Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
    J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of Diagnostic Sensitivity and Procedure-Related Pain of Concurrent Ultrasound-guided Fine-needle Aspiration and Core-needle Biopsy of Axillary Lymph Nodes in Patients with Suspected or Known breast cancer.
    Winkler N; Buxton J; Freer P; Raps E; Barraza G; Boucher K; Riegert J; Factor R
    J Breast Imaging; 2023 Jul; 5(4):436-444. PubMed ID: 38416904
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
    Vanacker H; Treilleux I; Schiffler C; Bieche I; Campone M; Patsouris A; Arnedos M; Cottu PH; Jacquin JP; Dalenc F; Pinton A; Servant N; Attignon V; Rouleau E; Morel A; Legrand F; Jimenez M; Andre F; Bachelot T
    Br J Cancer; 2024 Mar; 130(4):613-619. PubMed ID: 38182687
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary breast and Ovarian cancer.
    Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
    JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ERα/lkb1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure.
    Naimo GD; Forestiero M; Paolì A; Malivindi R; Gelsomino L; Győrffy B; Leonetti AE; Giordano F; Panza S; Conforti FL; Ruffo P; Panno ML; Mauro L; Andò S
    Int J Cancer; 2023 Sep; 153(6):1257-1272. PubMed ID: 37323038
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The efficacy of metformin as adjuvant to chemotherapy on IGF levels in non-diabetic female patients with progressive and non-progressive metastatic breast cancer.
    Essa NM; Elgendy MO; Gabr A; Mahmoud MM; Alharbi AA; Tashkandi HM; Salem HF; Harakeh S; Boshra MS
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5200-5210. PubMed ID: 37318494
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
    Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW
    BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline
    Yoshida H; Hiranuma K; Nakahara M; Kobayashi-Kato M; Tanase Y; Uno M; Shiraishi K; Ishikawa M; Kato T
    Int J Surg Pathol; 2024 Apr; 32(2):394-400. PubMed ID: 37226494
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Kaempferol induces mitochondrial dysfunction and mitophagy by activating the lkb1/AMPK/MFF pathway in breast precancerous lesions.
    Cao J; Ma X; Yan X; Zhang G; Hong S; Ma R; Wang Y; Ma M
    Phytother Res; 2023 Aug; 37(8):3602-3616. PubMed ID: 37086359
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Shahid I; Shoaib M; Raza RZ; Jahangir M; Abbasi SW; Riasat A; Akbar A; Mehnaz S
    Anticancer Agents Med Chem; 2023; 23(12):1388-1396. PubMed ID: 37005537
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence of Pathogenic Germline Mutations in 13 Hereditary cancer-Related Genes in breast cancer Patients in Narathiwat Province, Thailand.
    Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial-mesenchymal transition.
    Tzavlaki K; Ohata Y; Morén A; Watanabe Y; Eriksson J; Tsuchiya M; Kubo Y; Yamamoto K; Sellin ME; Kato M; Caja L; Heldin CH; Moustakas A
    J Cell Physiol; 2023 Apr; 238(4):790-812. PubMed ID: 36791282
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
    Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
    J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Strong Hereditary Predispositions to Colorectal cancer.
    Hryhorowicz S; Kaczmarek-Ryś M; Lis-Tanaś E; Porowski J; Szuman M; Grot N; Kryszczyńska A; Paszkowski J; Banasiewicz T; Pławski A
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553592
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer risk in patients with Peutz-Jeghers syndrome in Korea: a retrospective multi-center study.
    Kim SH; Kim ER; Park JJ; Kim ES; Goong HJ; Kim KO; Nam JH; Park Y; Lee SP; Jang HJ; ;
    Korean J Intern Med; 2023 Mar; 38(2):176-185. PubMed ID: 36517957
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.